Should you thrombolyse all or any stroke patients with baseline National Institutes of Health stroke scale scores < or = 5?
| Autor: | Alexandre Y Poppe, Nikolai Steffenhagen, Michael D. Hill, Shelagh B. Coutts, Alastair M. Buchan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: |
Male
medicine.medical_specialty Tissue plasminogen activator Risk Assessment Severity of Illness Index Fibrinolytic Agents Severity of illness medicine Odds Ratio Humans Thrombolytic Therapy Registries Baseline (configuration management) Stroke Aged Aged 80 and over Stroke scale business.industry Patient Selection Odds ratio Middle Aged medicine.disease United States Treatment Outcome Neurology National Institutes of Health (U.S.) Tissue Plasminogen Activator Physical therapy Female Neurology (clinical) Cardiology and Cardiovascular Medicine Risk assessment business Intracranial Hemorrhages Fibrinolytic agent medicine.drug |
| Zdroj: | Cerebrovascular diseases (Basel, Switzerland). 28(2) |
| ISSN: | 1421-9786 1015-9770 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|